Results 191 to 200 of about 50,913 (300)

Clinical predictors of stimulant efficacy in adults with ADHD. [PDF]

Ther Adv Psychopharmacol
DiSalvo M, Biederman J, O'Connor H, Iorini M, Green A, Woodworth KY, Wozniak J, Joshi G, Gabrieli J, Uchida M.   +9 more
europepmc   +1 more source

A case of tic improvement following tipepidine administration in a boy with Tourette syndrome comorbid with attention‐deficit/hyperactivity disorder and autism spectrum disorder

Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 3, September 2026.
Abstract Background Tourette Syndrome (TS) is defined by motor and vocal tics that begin in childhood and persist for over a year. TS causes difficulties in daily life and lowers self‐esteem, yet pharmacological treatment options for TS remain limited.
Masumi Tachibana, Tsuyoshi Sasaki
wiley   +1 more source

Manic switching is seldom observed during rTMS therapy for unipolar depression: Implications for antidepressant mechanisms

Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 3, September 2026.
Yuki Matsuda, Shun Takahashi
wiley   +1 more source

Medication Growth Following Diagnosis of Intellectual and Developmental Disabilities at Varying Ages Throughout Childhood

Pharmacoepidemiology and Drug Safety, Volume 35, Issue 9, September 2026.
ABSTRACT Purpose To characterize age‐related trajectories in psychotropic medication and polypharmacy use among children newly diagnosed with intellectual and developmental disabilities (IDD), addressing an evidence gap in longitudinal prescribing patterns.
Robert B. Christian, Izabela E. Annis, Neal A. deJong, Scott A. Davis, Phillip M. Hughes, Kathleen C. Thomas   +5 more
wiley   +1 more source

Reclaiming Pharmacovigilance: Bridging the Evidence-Practice Gap in Psychopharmacology. [PDF]

J Eval Clin Pract
De Las Cuevas C.
europepmc   +1 more source

Perception of ADHD and Compliance in Relation to ADHD Medication

Acta Psychiatrica Scandinavica, Volume 154, Issue 3, Page 212-222, September 2026.
ABSTRACT Introduction ADHD medication has proven effective for treating ADHD in adults. Large registry‐based studies have generally reported high discontinuation rates over time and focused on different risk factors, including comorbidity, gender, and socioeconomic status.
Kim Berg Johannessen, Pelle Lau Ishøy, Tine Houmann, Eline Levin, Per Hove Thomsen   +4 more
wiley   +1 more source

Correction: CCNP Innovations in Neuropsychopharmacology Award: The psychopharmacology of psychedelics: where the brain meets spirituality. [PDF]

J Psychiatry Neurosci
Gobbi G.
europepmc   +1 more source

Facial emotional expression in response to alcohol‐promoting commercials in individuals with alcohol use disorder: A pilot study

Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 3, September 2026.
Takefumi Ueno, Naho Nakayama, Shou Fukushima, Kazunori Matsuguchi, Kazuhiro Tojiki, Chenyu Qian, Shisei Tei, Hidehiko Takahashi, Junya Fujino   +8 more
wiley   +1 more source

Corrigendum to "Pharmacotherapy for post-traumatic stress disorder: systematic review and meta-analysis". [PDF]

Ther Adv Psychopharmacol
europepmc   +1 more source

Psychopharmacology

, 1995
Petrie, William M.
core